featured
Type 2 Diabetes in a High-Income Setting: Lifetime Risk, Life Expectancy, and Years of Life Lost
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Diabetes & Endocrinology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study
Lancet Diabetes Endocrinol 2022 Sep 29;[EPub Ahead of Print], D Tomic, JI Morton, L Chen, A Salim, EW Gregg, ME Pavkov, M Arffman, R Balicer, M Baviera, E Boersma-van Dam, R Brinks, B Carstensen, JCN Chan, YJ Cheng, S Fosse-Edorh, S Fuentes, H Gardiner, HL Gulseth, R Gurevicius, KH Ha, A Hoyer, G Jermendy, A Kautzky-Willer, I Keskimäki, DJ Kim, Z Kiss, P Klimek, M Leventer-Roberts, CY Lin, P Lopez-Doriga Ruiz, AOY Luk, S Ma, M Mata-Cases, D Mauricio, S McGurnaghan, T Imamura, SK Paul, A Peeters, S Pildava, A Porath, C Robitaille, MC Roncaglioni, T Sugiyama, KL Wang, SH Wild, N Yekutiel, JE Shaw, DJ MaglianoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.